 Dihydropyridines
"Dihydropyridines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.
| Descriptor ID |
D004095
|
| MeSH Number(s) |
D03.383.725.203
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dihydropyridines".
Below are MeSH descriptors whose meaning is more specific than "Dihydropyridines".
This graph shows the total number of publications written about "Dihydropyridines" by people in this website by year, and whether "Dihydropyridines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 1996 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 2001 | 2 | 1 | 3 | | 2003 | 0 | 1 | 1 | | 2017 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Dihydropyridines" by people in Profiles.
-
Lim CH, Ilic S, Alherz A, Worrell BT, Bacon SS, Hynes JT, Glusac KD, Musgrave CB. Benzimidazoles as Metal-Free and Recyclable Hydrides for CO2 Reduction to Formate. J Am Chem Soc. 2019 01 09; 141(1):272-280.
-
Goto RN, Sobral LM, Sousa LO, Garcia CB, Lopes NP, Mar?n-Prida J, Ochoa-Rodr?guez E, Verdecia-Reyes Y, Pardo-Andreu GL, Curti C, Leopoldino AM. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma. Eur J Pharmacol. 2018 Jan 15; 819:198-206.
-
Steiger SA, Li C, Backos DS, Reigan P, Natale NR. Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter. Bioorg Med Chem. 2017 06 15; 25(12):3223-3234.
-
Marras C, Gruneir A, Rochon P, Wang X, Anderson G, Brotchie J, Bell CM, Fox S, Austin PC. Dihydropyridine calcium channel blockers and the progression of parkinsonism. Ann Neurol. 2012 Mar; 71(3):362-9.
-
Leuranguer V, Dirksen RT, Beam KG. Potentiated L-type Ca2+ channels rectify. J Gen Physiol. 2003 Jun; 121(6):541-50.
-
Wilkens CM, Grabner M, Beam KG. Potentiation of the cardiac L-type Ca(2+) channel (alpha(1C)) by dihydropyridine agonist and strong depolarization occur via distinct mechanisms. J Gen Physiol. 2001 Nov; 118(5):495-508.
-
Chesnoy-Marchais D, Cathala L. Modulation of glycine responses by dihydropyridines and verapamil in rat spinal neurons. Eur J Neurosci. 2001 Jun; 13(12):2195-204.
-
Waugh DJ, Gaivin RJ, Zuscik MJ, Gonzalez-Cabrera P, Ross SA, Yun J, Perez DM. Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists. J Biol Chem. 2001 Jul 06; 276(27):25366-71.
-
Zuscik MJ, Gunter TE, Puzas JE, Rosier RN. Characterization of voltage-sensitive calcium channels in growth plate chondrocytes. Biochem Biophys Res Commun. 1997 May 19; 234(2):432-8.
-
Roth M, Eickelberg O, Kohler E, Erne P, Block LH. Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci U S A. 1996 May 28; 93(11):5478-82.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|